Ondansetron vs Testosterone
FDA Approved vs FDA Approved
avoid Mechanism-based · 75% Both Ondansetron and Testosterone carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently.
Molecular Data
Ondansetron Testosterone
Weight 293.36 Da 288.42 Da (base)
Half-life ~4 hours ~8 days (cypionate)
Type Carbazole derivative (C18H19N3O) Steroid hormone (C19H28O2)
Key Benefits
Ondansetron
01 Highly effective at controlling nausea and vomiting from a wide range of causes, including GLP-1 agonists, HCG, and nandrolone
02 Orally disintegrating tablet (ODT) dissolves on the tongue in seconds, ideal for use during active nausea when swallowing pills is difficult
03 Does not cause sedation, extrapyramidal symptoms, or prolactin elevation, unlike dopamine-blocking anti-emetics
04 Fast onset of action (15-30 minutes oral, near-immediate for ODT) with reliable 4-8 hour duration
05 Well-tolerated with a mild side effect profile at standard doses
06 Widely available as an inexpensive generic in multiple formulations
Testosterone
01 Restoration of normal testosterone levels in hypogonadal men
02 Increased lean muscle mass and strength
03 Improved bone mineral density and reduced fracture risk
04 Enhanced libido, sexual function, and erectile quality
05 Improved mood, energy, motivation, and cognitive clarity
06 Reduction in body fat percentage, particularly visceral fat
07 Increased red blood cell production and oxygen-carrying capacity
08 Improved insulin sensitivity and metabolic health markers
Dosing Protocols
Ondansetron
4-8 mg as needed / Up to 3 times daily
Testosterone
100-200 mg/week (TRT) / 1-2x per week (injectable)
TRT - Standard Replacement 100-200 mg/week 1-2x per week
TRT - Conservative Start 80-100 mg/week 2x per week (40-50 mg per injection)
TRT - Propionate Protocol 25-50 mg every other day Every other day or 3x per week
Performance Enhancement - Moderate 300-500 mg/week 2x per week
Performance Enhancement - Advanced 500-750 mg/week 2-3x per week
Side Effects
Ondansetron
Headache (most frequently reported side effect)
Constipation (5-HT3 blockade reduces gut motility)
Fatigue or dizziness
Dry mouth
Testosterone
Acne and oily skin (increased sebum production via DHT)
Water retention and bloating (estrogen-mediated)
Mild mood changes (irritability, increased assertiveness)
Increased hematocrit and hemoglobin (erythrocytosis)
Testicular atrophy (suppression of LH/FSH from exogenous testosterone)
Injection site pain, redness, or irritation
Increased body hair growth
Mild elevation in blood pressure
Contraindications
Known hypersensitivity to ondansetron or other 5-HT3 antagonists
Congenital long QT syndrome
Concurrent use of apomorphine (risk of severe hypotension and loss of consciousness)
Severe hepatic impairment (maximum dose should not exceed 8 mg/day)
Prostate cancer (active or history of hormone-sensitive prostate cancer)
Breast cancer in males
Polycythemia (hematocrit above 54% at baseline)
Uncontrolled severe heart failure
Untreated severe obstructive sleep apnea
Desire for near-term fertility (without concurrent HCG/FSH)
Pregnancy or potential exposure to pregnant women (Category X)
Hypersensitivity to testosterone or any formulation components
Research Evidence
Ondansetron Testosterone
Status FDA Approved FDA Approved
References 4 studies 5 studies
Latest — June 2023
FDA Approved Yes Yes
This comparison is for educational and research purposes only. Consult a healthcare professional before use.